Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
77 /100
CRITICAL RISK
Score updated Oct 13, 2026

INM — InMed Pharmaceuticals Inc. Dilution Risk Tracker

Track INM dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INM — Get alerts when the score changes →

As of October 13, 2026, InMed Pharmaceuticals Inc. (INM) has a DilutionWatch DilutionScore of 77/100, rated CRITICAL dilution risk. InMed Pharmaceuticals Inc. has a market capitalization of $7.47M, 5.49M shares outstanding. Stored dilution-related fields include shelf registration capacity of $50.00M, ATM program capacity of $1.21M, 694.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
65
📊 Float Risk
72
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 51%
🔄 Reverse Split model est. 65%
• 50-day avg $0.85 below $1 exchange minimum
• 8 months cash with weak price
💰 Capital Raise model 53%
• Under 12 months cash (8mo)
• Active shelf registration ($50M, 669% of market cap)
📜 Warrant Exercise model 15%
• Warrant overhang: 12.6% of shares outstanding
🔔 Track INM — Get forecast alerts →

Market Data

Market Cap$7.47M
Shares Outstanding5.49M
Float1.97M
Cash$5.20M
Debt$29.3K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore77/100DilutionWatch score record
Shares Outstanding5.49MVerified float table or market cache
Public Float1.97MVerified float table or market cache
Market Cap$7.47MMarket data cache
Cash Runway7.9 monthsDilutionWatch score inputs
Shelf Capacity$50.00MSEC-derived dilution fields
ATM Capacity$1.21MSEC-derived dilution fields
Outstanding Warrants694.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 424B5 1, 8-K 1, EFFECT 1, S-3 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

53.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track INM for full holder detail →

Short Interest

Short Interest34.1K
Days to Cover1.0
% of Float1.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-09-09
8-K 8K EVENT 2026-04-27
424B5 ATM 2026-04-03
EFFECT EFFECT 2026-03-30
S-3 SHELF 2026-03-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual INM Dilution Snapshot

InMed Pharmaceuticals Inc. (INM) has a DilutionScore of 77/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

INM's DilutionScore is currently 77/100 (Critical risk), with 3 score changes tracked over 89 days. The score improved from 74/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202677/100CRITICAL16 days
Sep 14 – Sep 27, 202674/100HIGH14 days
Aug 14 – Sep 13, 202671/100HIGH30 days
Jul 16 – Aug 13, 202678/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

INM shares outstanding have decreased 0.0% from 3.31M (Apr 2026) to 3.31M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 20263.31M1.97M▼ 19.84%
May 11, 20263.31M2.46M▲ 13.53%
Apr 13, 20263.31M2.16M▲ 3.51%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track INM Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment INM files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking INM — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INM
INM FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.